As recommended in the 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management, the use of thyroid hormone to decrease TSH should be discouraged in the absence of elevated TSH (2). The gene discussed is TG; the disease is thyroid nodule.